Business Max Stendahl Boston Business Journal Report: IPO for Gene Editor Published March 5, 2018 • Updated on March 19, 2018 at 1:43 pm Biotech reporter Max Stendahl joins necn to discuss his story, "Bedford gene editing startup Homology plots $100M IPO."